Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300072199Phase 4Not yet recruiting
Phase 4, randomised trial of dibotermin alfa in Neck Of Femur Fracture (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoints: Time of fracture union and Surgical complications. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300072199.